Botanix Pharmaceuticals Is A Biotechnology Company Listed On Theasxasxbotwith Headquarters In Perthaustraliaand Philadelphiausathecompany Specializes In Clinical Stagedermatology And Antimicrobial Treatmentsfocusing On Synthetic Cannabinoid Based Therapies That Utilizecannabidiolcbdand Its Proprietary Skin Delivery Technologypermetrexa C Thecompany S Product Pipelineincludes Several Innovativetherapies Aimed At Addressing Common Dermatological Conditionstheseincludebtx 150 For Moderateto Severeacnebtx 1702 For Rosaceaand Btx 1204A For Moderateatopic Dermatitisadditionallybtx 1801 Targets Infections In Hemodialysis Patients And Other Antimicrobial Applicationsall Products Leveragethepermetrexa C Delivery System To Enhanceskin Absorptionand Botanix Is Also Exploring Veterinary Applications For Atopic Dermatitis Botanix Aims To Improvepatient Outcomes By Addressing Unmet Needs In Dermatology And Antimicrobial Resistancepositioning Itself As A Leader In Cannabinoid Based Dermatological Treatments
